SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-122530
Filing Date
2019-04-26
Accepted
2019-04-26 16:45:03
Documents
5
Period of Report
2019-06-07
Effectiveness Date
2019-04-26

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT d663468ddef14a.htm DEF 14A 340238
2 GRAPHIC g663468g18g45.jpg GRAPHIC 1587
3 GRAPHIC g663468g19c14.jpg GRAPHIC 58593
4 GRAPHIC g663468g59i74.jpg GRAPHIC 56980
5 GRAPHIC g663468g78e51.jpg GRAPHIC 1552
  Complete submission text file 0001193125-19-122530.txt   505385
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

IRS No.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36571 | Film No.: 19772321
SIC: 3841 Surgical & Medical Instruments & Apparatus